1-4 of 4
Wilbert B. Copeland
Close
Sort by
Journal Articles

Efficacy and Safety of Azacitidine (AZA) in Combination with the Anti-PD-L1 Durvalumab (durva) for the Front-Line Treatment of Older Patients (pts) with Acute Myeloid Leukemia (AML) Who Are Unfit for Intensive Chemotherapy (IC) and Pts with Higher-Risk Myelodysplastic Syndromes (HR-MDS): Results from a Large, International, Randomized Phase 2 Study

Amer M. Zeidan, MBBS, MHS, James Cavenagh, Maria Teresa Voso, David Taussig, Mar Tormo, Isaac Boss, Wilbert B. Copeland, Vanessa E. Gray, Alessandro Previtali, Tim O'Connor, Shelonitda Rose, CL Beach, Lewis R. Silverman
Journal: Blood
Blood (2019) 134 (Supplement_1): 829.
https://doi.org/10.1182/blood-2019-122896
Published: 2019
Journal Articles

Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma

Mary H Young, PhD, Sam A Danziger, Alison Fitch, Frank Schmitz, MD PhD, Jake Gockley, PhD, Mark McConnell, PhD, David Reiss, PhD, Wilbert B. Copeland, PhD, Sarah K Johnson, PhD, Katie Newhall, PhD, Robert Hershberg, MD PhD, Teri Foy, PhD, Alexander Ratushny, PhD, Brian A Walker, PhD, Andrew Dervan, Gareth Morgan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 243.
https://doi.org/10.1182/blood-2018-99-113042
Published: 2018
Journal Articles

Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies

Samuel A Danziger, PhD, Mark McConnell, PhD, Jake Gockley, PhD, Mary Young, PhD, Adam Rosenthal, MS, Frank Schmitz, MD PhD, David Reiss, PhD, Phil Farmer, Cody Ashby, PhD, Michael A Bauer, PhD, Frits van Rhee, MD PhD, Faith E. Davies, MD, Maurizio Zangari, MD, Nathan Petty, MS, CCRP, Wilbert B. Copeland, PhD, Brian A. Fox, PhD, Antje Hoering, PhD, Alison Fitch, Katie Newhall, PhD, Bart Barlogie, MD PhD, Brian A Walker, PhD, Matthew Trotter, PhD, Rob Hershberg, MD PhD, Andrew Dervan, Alexander Ratushny, PhD, Gareth Morgan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1882.
https://doi.org/10.1182/blood-2018-99-113169
Published: 2018
Journal Articles

Comprehensive Immune Profiling from Peripheral Blood and Bone Marrow in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma Patients Reflects Differences in Immune Subsets and Activation Status

Greg E. Pietz, BS, MS, Mark Tometsko, BSc, Wilbert B. Copeland, PhD, Elizabeth Whalen, PhD, Frank Schmitz, MD PhD, Ethan G. Thompson, PhD, Amit Agarwal, MD PhD, Teresa Foy, PhD, Lauren Buchholz, BS, Vitalina Komashko, PhD, Justine Dell'Aringa, BSc, Brian A. Fox, PhD, Kathryn Newhall, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3161.
https://doi.org/10.1182/blood-2018-99-115107
Published: 2018